Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences Accel-Amplicon Custom NGS Panels

Swift Biosciences has launched Accel-Amplicon Custom NGS Panels, a targeted DNA sequencing product that enables clinical researchers to rapidly design highly focused panels to discover, validate, and screen disease genes and their variants. The platform-agnostic panel supports a wide range of input sample types including fresh and fresh-frozen tissue, whole blood, blood spot cards, formalin-fixed paraffin-embedded tissue, cell-free DNA, circulating tumor DNA, buccal swabs, whole genome amplified DNA and purified DNA. The panels require 10 nanograms of sample input, and enables library prep in under two hours. Swift said that it also partnered with informatics firm Genialis to integrate alignment, trimming, QC, and variant calling into one simple pipeline.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.